Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Ermium Therapeutics

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

Overview Structured Data Issues Contributors Activity

ermium.com

Is a

Organization

Company

Company attributes

Industry

Pharmaceutical industry

Location

B2X

CEO

Pitchbook URL

pitchbook.com/profiles...294503-32

Number of Employees (Ranges)

1 – 10

Email Address

contact@ermium.com0

Full Address

29 Rue du Faubourg Saint-Jacques 75014 Paris, France0

Investors

Kurma Partners

Fountain Healthcare Partners

IDInvest Partners

DOMAIN Therapeutics

Founded Date

January 1, 2019

Total Funding Amount (USD)

13,000,000

Latest Funding Round Date

July 1, 2022

Latest Funding Type

Series A

Country

France

Headquarters

Paris

Other attributes

Latest Funding Round Amount (USD)

6,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Ermium Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API